Multiple myeloma (MM) is a hematological malignancy characterized by abnormal plasma cell proliferation within the bone marrow which leads to progressive bone marrow failure, skeletal osteolytic lesions, and renal insufficiency, thus severely...
Read More »Exosome-transferred lncRNAs at the core of cancer bone lesions
Exosome-mediated transfer of regulatory RNAs is a key feature that enables cancer cells to shape a tumor-promoting environment. Cancers growing in the bone can use this communication modality to...
Read More »Monitoring multiple myeloma through tumor-derived exosomes
Tumor-derived exosomes (TDEs) play a pivotal role in tumor establishment and progression, and are emerging biomarkers for tumor diagnosis in personalized medicine. To date, there is a lack of efficient technology platforms for exosome isolation and characterization. Multiple myeloma (MM) ...
Read More »Residual matrix from different separation techniques impacts exosome biological activity
Exosomes are gaining a prominent role in research due to their intriguing biology and several therapeutic opportunities. However, their accurate purification from body fluids and detailed physicochemical characterization remain open issues. Researchers from the University of Brescia, Italy isolated exosomes ...
Read More »Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
The interplay between bone marrow stromal cells (BMSCs) and multiple myeloma (MM) cells plays a crucial role in MM pathogenesis by secreting growth factors, cytokines, and extracellular vesicles. Exosomes are 40-100 nm diameter membranous vesicles constitutively released by almost all ...
Read More »